Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Hyperpolarised 13 C-MRI metabolic and functional imaging: an emerging renal MR diagnostic modality.

Tytuł:
Hyperpolarised C-MRI metabolic and functional imaging: an emerging renal MR diagnostic modality.
Autorzy:
Pedersen M; Comparative Medicine Lab, Aarhus University, Aarhus, Denmark.
Ursprung S; Department of Radiology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK.
Jensen JD; Department of Renal Medicine, Aarhus University Hospital, Aarhus, Denmark.
Jespersen B; Department of Renal Medicine, Aarhus University Hospital, Aarhus, Denmark.
Gallagher F; Department of Radiology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK.
Laustsen C; MR Research Centre, Department of Clinical Medicine, Aarhus University Hospital, Palle Juul Jensens Boulevard, 8200, Aarhus N, Denmark. .
Źródło:
Magma (New York, N.Y.) [MAGMA] 2020 Feb; Vol. 33 (1), pp. 23-32. Date of Electronic Publication: 2019 Nov 28.
Typ publikacji:
Journal Article; Review
Język:
English
Imprint Name(s):
Publication: 2003- : Heidelberg : Springer
Original Publication: New York, NY : Chapman & Hall, c1993-
MeSH Terms:
Carbon Isotopes*
Magnetic Resonance Imaging*
Positron-Emission Tomography*
Kidney/*diagnostic imaging
Kidney Diseases/*diagnostic imaging
Animals ; Biomarkers/metabolism ; Glycolysis ; Humans ; Hypoxia ; Image Processing, Computer-Assisted/methods ; Kidney/metabolism ; Oxidation-Reduction
References:
Magn Reson Med. 2018 Aug;80(2):696-702. (PMID: 29285782)
Nat Rev Urol. 2010 May;7(5):277-85. (PMID: 20448661)
Endocr Rev. 2004 Dec;25(6):971-1010. (PMID: 15583025)
Magn Reson Med. 2016 Dec;76(6):1900-1904. (PMID: 26822562)
Neuroimage. 2019 Apr 1;189:171-179. (PMID: 30639333)
J Am Chem Soc. 2017 May 17;139(19):6629-6634. (PMID: 28467066)
Tomography. 2017 Sep;3(3):146-152. (PMID: 30042978)
Eur Urol. 2017 Dec;72(6):1028-1029. (PMID: 28765011)
Diabetologia. 2018 Feb;61(2):445-454. (PMID: 28936623)
NMR Biomed. 2017 Oct;30(10):. (PMID: 28708304)
NMR Biomed. 2011 Oct;24(8):927-32. (PMID: 21416540)
Physiol Rep. 2017 Mar;5(6):. (PMID: 28336821)
Am J Physiol Renal Physiol. 2012 Jun 15;302(12):F1658-62. (PMID: 22492940)
Sci Rep. 2017 Nov 22;7(1):16002. (PMID: 29167446)
Magn Reson Med. 2017 Sep;78(3):1131-1135. (PMID: 27690362)
Magn Reson Med. 2017 Jan;77(1):65-73. (PMID: 27859575)
BJR Case Rep. 2019 May 2;5(3):. (PMID: 31428445)
Sci Rep. 2017 Jan 17;7:40812. (PMID: 28094329)
Annu Rev Biomed Eng. 2005;7:255-85. (PMID: 16004572)
Magn Reson Med. 2017 Apr;77(4):1429-1437. (PMID: 27098724)
Physiol Rep. 2014 Dec 11;2(12):. (PMID: 25501426)
Physiol Rep. 2016 Mar;4(5):. (PMID: 26997625)
J Nucl Med. 1995 Sep;36(9):1595-601. (PMID: 7658216)
Acad Radiol. 2006 Aug;13(8):932-42. (PMID: 16843845)
FEBS Lett. 1975 Apr 15;53(1):26-8. (PMID: 1140392)
PLoS One. 2013;8(1):e53849. (PMID: 23308289)
Am J Physiol Renal Physiol. 2017 Mar 1;312(3):F465-F473. (PMID: 27654895)
Magn Reson Med. 2017 Apr;77(4):1650-1655. (PMID: 27172094)
Curr Opin Investig Drugs. 2010 Apr;11(4):402-17. (PMID: 20336588)
Magn Reson Med. 2001 Jul;46(1):1-5. (PMID: 11443703)
Circ Res. 2016 Nov 11;119(11):1177-1182. (PMID: 27635086)
Physiol Rep. 2015 Aug;3(8):. (PMID: 26272734)
Kidney Int. 2000 Jun;57(6):2511-8. (PMID: 10844620)
Diabetes. 2015 Feb;64(2):344-52. (PMID: 25187363)
Magn Reson Med. 2016 Dec;76(6):1895-1899. (PMID: 27670826)
Diabetes Metab Res Rev. 2013 Feb;29(2):125-9. (PMID: 23166087)
Contrib Nephrol. 2018;193:45-54. (PMID: 29393158)
NMR Biomed. 2018 Jan;31(1):. (PMID: 29130537)
Hypertension. 2007 Jul;50(1):242-7. (PMID: 17502492)
Magn Reson Med. 2016 Nov;76(5):1524-1530. (PMID: 27548739)
Sci Transl Med. 2013 Aug 14;5(198):198ra108. (PMID: 23946197)
J Cardiovasc Magn Reson. 2013 Oct 08;15:93. (PMID: 24103786)
NMR Biomed. 2016 Aug;29(8):1038-47. (PMID: 27295304)
Magn Reson Imaging. 2014 Jul;32(6):781-5. (PMID: 24631714)
Clin Exp Pharmacol Physiol. 2006 Oct;33(10):961-7. (PMID: 17002675)
Am J Physiol Renal Physiol. 2017 Jan 1;312(1):F192-F199. (PMID: 28069660)
Acta Physiol (Oxf). 2018 Apr;222(4):e12999. (PMID: 29159875)
Am J Physiol Renal Physiol. 2016 Apr 15;310(8):F717-F725. (PMID: 26764206)
Magn Reson Med. 2018 Nov;80(5):2073-2080. (PMID: 29520870)
J Am Soc Nephrol. 2013 Mar;24(4):537-41. (PMID: 23334390)
Proc Natl Acad Sci U S A. 2003 Sep 2;100(18):10158-63. (PMID: 12930897)
Neoplasia. 2019 Jan;21(1):1-16. (PMID: 30472500)
Magn Reson Med. 2015 Aug;74(2):558-63. (PMID: 26014387)
Proc Natl Acad Sci U S A. 2012 Aug 14;109(33):13374-9. (PMID: 22837393)
Histochem J. 1986 Jan;18(1):45-53. (PMID: 2423478)
Front Physiol. 2016 Mar 01;7:72. (PMID: 26973539)
Tomography. 2016 Jun;2(2):125-135. (PMID: 27570835)
Diabetes. 2016 Dec;65(12):3544-3551. (PMID: 27561726)
Cancer Res. 2018 Jul 15;78(14):3755-3760. (PMID: 29769199)
AJR Am J Roentgenol. 2015 Mar;204(3):W273-81. (PMID: 25714312)
Magn Reson Med. 2018 Apr;79(4):1862-1869. (PMID: 29314217)
MAGMA. 2009 Aug;22(4):251-6. (PMID: 19367422)
Kidney Int. 2014 Jul;86(1):67-74. (PMID: 24352155)
Int J Biomed Imaging. 2007;2007:63234. (PMID: 17728841)
Magn Reson Med. 2017 May;77(5):1741-1748. (PMID: 28261868)
NMR Biomed. 2019 Jan;32(1):e4028. (PMID: 30426590)
Magn Reson Med. 2019 Mar;81(3):2184-2194. (PMID: 30357898)
Clin Exp Pharmacol Physiol. 2013 Feb;40(2):138-47. (PMID: 23360244)
Cancer Res. 2019 Jan 1;79(1):242-250. (PMID: 30459151)
Magn Reson Imaging. 2012 Dec;30(10):1367-72. (PMID: 22819176)
IEEE Trans Med Imaging. 2014 Feb;33(2):362-71. (PMID: 24235273)
Free Radic Biol Med. 2016 Nov;100:175-181. (PMID: 27117029)
Cancers (Basel). 2018 Sep 05;10(9):. (PMID: 30189677)
Neoplasia. 2011 Feb;13(2):81-97. (PMID: 21403835)
Am J Physiol. 1978 Sep;235(3):F246-53. (PMID: 211858)
Magn Reson Med. 2016 Feb;75(2):515-8. (PMID: 26584247)
Magn Reson Med. 2004 Nov;52(5):1043-51. (PMID: 15508152)
J Magn Reson. 2018 May;290:46-59. (PMID: 29567434)
Sci Rep. 2018 Feb 1;8(1):2088. (PMID: 29391429)
Grant Information:
16628 United Kingdom CRUK_ Cancer Research UK; 27150 United Kingdom CRUK_ Cancer Research UK
Contributed Indexing:
Keywords: Hyperpolarisation; Kidney; MRI; Metabolism; Renal
Substance Nomenclature:
0 (Biomarkers)
0 (Carbon Isotopes)
FDJ0A8596D (Carbon-13)
Entry Date(s):
Date Created: 20191130 Date Completed: 20210120 Latest Revision: 20240210
Update Code:
20240210
DOI:
10.1007/s10334-019-00801-y
PMID:
31782036
Czasopismo naukowe
Magnetic resonance imaging (MRI) is a well-established modality for assessing renal morphology and function, as well as changes that occur during disease. However, the significant metabolic changes associated with renal disease are more challenging to assess with MRI. Hyperpolarized carbon-13 MRI is an emerging technique which provides an opportunity to probe metabolic alterations at high sensitivity by providing an increase in the signal-to-noise ratio of 20,000-fold or more. This review will highlight the current status of hyperpolarised 13 C-MRI and its translation into the clinic and how it compares to metabolic measurements provided by competing technologies such as positron emission tomography (PET).

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies